Keywords
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

24543 Search results.

Relevance Rating New first Old first

S.0010_DIVI Notaufnahmeprotokoll_Basis - Basis

- 7/20/18 - 1 form, 5 itemgroups, 80 items, 2 languages
Itemgroups: Patient Information,Informations,Vital signs,Diagnoses and Examinations,Anamnesis
Emergency protocol by the DIVI (Deutsche Interdisziplinre Vereinigung für Intensiv- und Notfallmedizin). ODM derived from "Notaufnahmeprotokoll Modul Basis V2015.1".

EHR4CR CTE Data Inventory

- 4/21/18 - 1 form, 14 itemgroups, 133 items, 1 language
Itemgroups: Adverse Events,Concomitant Medication,Demographics,Disease Characteristics,Disposition,ECG,Laboratory,Laboratory Data,Medical History,Patient Reported Outcome,Substance Use,Surgery,Tumor Response,Vital Signs
Data Inventory for Clinical Trial Execution in the EHR4CR project. https://www.ncbi.nlm.nih.gov/pubmed/27875988 DOI for citation: 10.21961/MDM:17994

Eligibility Type 2 Diabetes NCT00641251

- 4/21/18 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT00641251

Eligibility Type 2 Diabetes NCT00508599

- 4/21/18 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
The Effects of Two Days of Bedrest on Insulin Resistance in Type 2 Diabetics; ODM derived from: https://clinicaltrials.gov/show/NCT00508599

Eligibility Leukemia, Myeloid NCT00512083

- 1/10/18 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria,Exclusion Criteria
Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00512083

Telemedical Interventional Management in Heart Failure II (TIM-HF II) NCT01878630 - Baseline Visit

- 11/14/17 - 1 form, 10 itemgroups, 71 items, 2 languages
Itemgroups: Physical Examination / Medical History taking,Signs and Symptoms of heart failure,Cardiovascular Diseases,Comorbidities,Current medication,Cardiovascular interventions,Implantation of a cardiac device,Hematology,ECG,Baseline visit
Short title: TIM-HF II Permission to publish granted by: Prof. Dr. Friedrich Köhler, FESC Charité - Universitätsmedizin Berlin Further study details on: https://www.clinicaltrials.gov/ct2/show/NCT01878630 Baseline Visit (BV-Form)

Demography Screening Ropinirole Parkinson Disease 101468/165 - Demography Screening

- 10/15/17 - 1 form, 1 itemgroup, 10 items, 1 language
Itemgroup: Demography
Study Part: Demography Screening. An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Informed consent Visit 1 Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381 - Informed consent Visit 1

- 7/16/17 - 1 form, 1 itemgroup, 4 items, 1 language
Itemgroup: Informed consent
Study part: Informed consent Visit 1. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381

Lab tests cardiac surgery UKM - Lab tests

- 7/10/17 - 1 form, 2 itemgroups, 22 items, 2 languages
Itemgroups: Patient demographics,Lab tests
Lab tests form converted to ODM format. Routine documentation of University Hospital of Münster. Publication granted by Univ.-Prof. Dr. med. Sven Martens.

NIHSS - NIH Stroke Scale

- 9/20/21 - 1 form, 1 itemgroup, 16 items, 9 languages
Itemgroup: NIHSS
https://en.wikipedia.org/wiki/National_Institutes_of_Health_Stroke_Scale

NURSING ASSESSMENT (adult) - HIS

- 6/8/17 - 1 form, 36 itemgroups, 383 items, 2 languages
Itemgroups: Nursing Assessment,Neurological status,GLASGOW COMA SCALE,PUPILS,ORIENTATION,Cardiovascular,Eyes Ear Nose & Throat,EYES,EARS,NOSE,THROAT,Respiratory,Gastrointestinal,Genitourinary,Musculoskeletal,Skin,PRESSURE ULCER ASSESSMENT,Wound(s),INCISION(S),Nutrition,IV Therapy,Safety,Hendrich II Fall Risk Assessment,INTERVENTIONS,IMPAIRED MOBILITY RISK,ALTERED ELIMINATION,HIGH RISK FALL MEDICATIONS (ANTIEPILEPTICS & BENZODIAZEPINES),INTERVENTIONS (FOR ONCOLOGY USE ONLY),ONN Unit specific,Antepartum specific,Post partum specific,Post Surgical,ADOLESCENT INTERACTION,GERIATRIC INTERVENTION (65+),Hendrich Fall Risk,SUGGESTED INTERVENTIONS
Form from HIS OpenVista

GSK 100262 Clinical Study Report Demography

- 5/17/17 - 1 form, 2 itemgroups, 4 items, 1 language
Itemgroups: Date of assessment,Demography
GSK 100262 Clinical Study Report Demography

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial